These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12019580)

  • 21. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke.
    Sun SF; Hsu CW; Hwang CW; Hsu PT; Wang JL; Yang CL
    Phys Ther; 2006 Oct; 86(10):1387-97. PubMed ID: 17012643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A; McAfee AL; Kuhn ER; Fyffe J
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum Toxin Injections and Electrical Stimulation for Spastic Paresis Improve Active Hand Function Following Stroke.
    Lee JM; Gracies JM; Park SB; Lee KH; Lee JY; Shin JH
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30366407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of focal muscle vibration on hemiplegic upper extremity spasticity in individuals with stroke: A systematic review.
    Alashram AR; Padua E; Romagnoli C; Annino G
    NeuroRehabilitation; 2019 Dec; 45(4):471-481. PubMed ID: 31868686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke.
    Santamato A; Panza F; Filoni S; Ranieri M; Solfrizzi V; Frisardi V; Dellomonaco A; Amoruso MT; Amoruso L; Kehoe PG; Megna M; Fiore P
    Brain Inj; 2010; 24(9):1108-12. PubMed ID: 20569045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.
    Gupta AD; Chu WH; Howell S; Chakraborty S; Koblar S; Visvanathan R; Cameron I; Wilson D
    Syst Rev; 2018 Jan; 7(1):1. PubMed ID: 29304876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.
    Wu T; Li JH; Song HX; Dong Y
    Top Stroke Rehabil; 2016 Jun; 23(3):217-23. PubMed ID: 27077980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z; Hlustík P; Otruba P; Herzig R; Kanovský P
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spasticity must be treated by botulinum toxin with rehabilitaiton].
    Masakado Y
    Rinsho Shinkeigaku; 2013; 23(11):1261-3. PubMed ID: 24291950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronox versus BOTOX in the Treatment of Post-Stroke Upper Limb Spasticity: A Multicenter Randomized Controlled Trial.
    Seo HG; Paik NJ; Lee SU; Oh BM; Chun MH; Kwon BS; Bang MS
    PLoS One; 2015; 10(6):e0128633. PubMed ID: 26030192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM; Chen JJ; Wu YN; Wang YL; Huang SC; Piotrkiewicz M
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors.
    Franceschini M; Iocco M; Molteni F; Santamato A; Smania N;
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):525-33. PubMed ID: 24963604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH; Chun MH; Paik NJ; Park YG; Lee SU; Kim MW; Kim DK
    Clin Rehabil; 2017 Sep; 31(9):1179-1188. PubMed ID: 28118733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of gait parameters to predict the effectiveness of botulinum toxin injection in the spastic rectus femoris muscle of stroke patients with stiff knee gait.
    Roche N; Boudarham J; Hardy A; Bonnyaud C; Bensmail B
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):361-70. PubMed ID: 25213306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.